溶血栓藥 的英文怎麼說
中文拼音 [róngxiěshuānyào]
溶血栓藥
英文
thrombolytics-
The systemic administration of heparin, warfarin or streptokinase is determined to have a thrombolytic effect but risk systemic or ocular bleeding and appeare to be unhelpul for improving visual acuity
全身應用肝素、華法令或鏈激酶溶栓藥物已被證實對提高視力沒有明確幫助,並且存在全身或局部出血的風險。Patients who receied the thrombolytic therapy at the uniersity ' s burn center were more likely to keep their frostbitten fingers and toes than patients who went without the drug
在猶他大學燒傷中心接受溶拴治療的燒傷病人較那些沒有接受康血栓藥物的病人更有可能保住自己凍傷的手指和腳趾。The six interventions studied included : corticosteroids for traumatic head injury, antifibrinolytics for hemorrhage, thrombolysis for ischemic stroke, tirilazad for ischemic stroke, antenatal corticosteroids to prevent neonatal respiratory disease syndrome, and bisphosphonates to treat osteoporosis
這6種干預包括:糖皮質激素治療腦外傷,抗纖藥治療出血,溶栓要治療缺血性中風,替拉扎特治療缺血性中風,出生前使用糖皮質激素預防新生兒呼吸窘迫綜合征,膦酸鹽治療骨質疏鬆癥。1 fu y , huang y , huang px , et al. research tendency of thrombolysis of acute ischemic cerebrovascular disease using traditional chinese medicine and metabonomic study. liaoning zhong yi za zhi. 2006 ; 33 ( 6 ) : 662 ? 664. chinese
付于,黃燕,黃培新,等。急性缺血性腦血管病的中藥溶栓治療與代謝組學的研究趨勢。遼寧中醫雜志。 2006 ; 33 ( 6 ) : 662 ? 664Tissue - type plasminogn activator ( t - pa ) is a kind of high efficient and specific thrombolytic medicine and is used widely to cure blood vessel embolism diseases. at present, t - pa has been expressed in e. coli
組織型纖溶酶原激活劑( tissue - typeplasminogenactivator , t - pa )是一種高效特異的溶血栓藥物,被廣泛地應用於血管栓塞性疾病的治療。分享友人